TY - JOUR
T1 - 30 years of polio campaigns in Ethiopia, India and Nigeria
T2 - The impacts of campaign design on vaccine hesitancy and health worker motivation
AU - Neel, Abigail H.
AU - Closser, Svea
AU - Villanueva, Catherine
AU - Majumdar, Piyusha
AU - Gupta, S. D.
AU - Krugman, Daniel
AU - Akinyemi, Oluwaseun Oladapo
AU - Deressa, Wakgari
AU - Kalbarczyk, Anna
AU - Alonge, Olakunle
N1 - Funding Information:
1International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA 2SDG School of Public Health, Indian Institute of Health Management Research, Jaipur, Rajasthan, India 3Anthropology, Middlebury College, Middlebury, Vermont, USA 4Health Policy and Management, University of Ibadan College of Medicine, Ibadan, Nigeria 5Preventive Medicine, Addis Ababa University, Addis Ababa, Ethiopia Acknowledgements We thank members of the STRIPE research consortium that were involved in data collection in Ethiopia, India, and Nigeria including Eme Owoaje, Assefa Seme, D.K. Mangal, and Neeraj Sharma. We also thank members of the Polio Eradication Impacts study in Ethiopia, India and Nigeria, including Kenneth Maes, Hailom Banteyerga Amaha, Ranjani Gopinath, Ismaila Zango Mohammed, Aminu Mohammed Dukku, Adam Koon, Jessie Ebersole, and Aftab Pasha. Contributors Literature Review: AHN, SC, CV, DK. Study design: SC, OA. Data collection: SC, PM, OA, WD, SDG. Data analysis: AHN, SC, CV, DK. Figures: AHN, SC, CV, DK, AK. Manuscript draft: AHN, SC, CV. Manuscript review and approval: AHN, SC, CV, PM, OA, WD, SDG, DK, AK. Funding Funding for these studies was provided by the Bill & Melinda Gates Foundation. The funders have had no involvement in the development of this paper. Competing interests None declared.
Publisher Copyright:
© 2021 A.D.A.C.. All rights reserved.
PY - 2021/8/3
Y1 - 2021/8/3
N2 - Introduction The debate over the impact of vertical programmes, including mass vaccination, on health systems is long-standing and often polarised. Studies have assessed the effects of a given vertical health programme on a health system separatelyâ €¯from the goals of the vertical programme itself. Further, these health system effects are often categorised as either positive or negative. Yet health systems are in fact complex, dynamic and tightly linked. Relationships between elements of the system determine programme and system-level outcomes over time. Methods We constructed a causal loop diagram of the interactions between mass polio vaccination campaigns and government health systems in Ethiopia, India and Nigeria, working inductively from two qualitative datasets. The first dataset was 175 interviews conducted with policymakers, officials and frontline staff in these countries in 2011-2012. The second was 101 interviews conducted with similar groups in 2019, focusing on lessons learnt from polio eradication. Results Pursuing high coverage in polio campaigns, without considering the dynamic impacts of campaigns on health systems, cost campaign coverage gains over time in weaker health systems with many campaigns. Over time, the systems effects of frequent campaigns, delivered through parallel structures, led to a loss of frontline worker motivation, and an increase in vaccine hesitancy in recipient populations. Co-delivery of interventions helped to mitigate these negative effects. In stronger health systems with fewer campaigns, these issues did not arise. Conclusion It benefits vertical programmes to reduce the construction of parallel systems and pursue co-delivery of interventions where possible, and to consider the workflow of frontline staff. Ultimately, for health campaign designs to be effective, they must make sense for those delivering and receiving campaign interventions, and must take into account the complex, adaptive nature of the health systems in which they operate.â
AB - Introduction The debate over the impact of vertical programmes, including mass vaccination, on health systems is long-standing and often polarised. Studies have assessed the effects of a given vertical health programme on a health system separatelyâ €¯from the goals of the vertical programme itself. Further, these health system effects are often categorised as either positive or negative. Yet health systems are in fact complex, dynamic and tightly linked. Relationships between elements of the system determine programme and system-level outcomes over time. Methods We constructed a causal loop diagram of the interactions between mass polio vaccination campaigns and government health systems in Ethiopia, India and Nigeria, working inductively from two qualitative datasets. The first dataset was 175 interviews conducted with policymakers, officials and frontline staff in these countries in 2011-2012. The second was 101 interviews conducted with similar groups in 2019, focusing on lessons learnt from polio eradication. Results Pursuing high coverage in polio campaigns, without considering the dynamic impacts of campaigns on health systems, cost campaign coverage gains over time in weaker health systems with many campaigns. Over time, the systems effects of frequent campaigns, delivered through parallel structures, led to a loss of frontline worker motivation, and an increase in vaccine hesitancy in recipient populations. Co-delivery of interventions helped to mitigate these negative effects. In stronger health systems with fewer campaigns, these issues did not arise. Conclusion It benefits vertical programmes to reduce the construction of parallel systems and pursue co-delivery of interventions where possible, and to consider the workflow of frontline staff. Ultimately, for health campaign designs to be effective, they must make sense for those delivering and receiving campaign interventions, and must take into account the complex, adaptive nature of the health systems in which they operate.â
KW - health systems
KW - poliomyelitis
KW - vaccines
UR - http://www.scopus.com/inward/record.url?scp=85112092927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112092927&partnerID=8YFLogxK
U2 - 10.1136/bmjgh-2021-006002
DO - 10.1136/bmjgh-2021-006002
M3 - Article
C2 - 34344665
AN - SCOPUS:85112092927
SN - 2059-7908
VL - 6
JO - BMJ Global Health
JF - BMJ Global Health
IS - 8
M1 - e006002
ER -